<DOC>
	<DOCNO>NCT01348711</DOCNO>
	<brief_summary>To assess role uterine artery maternal serum PlGf sflt-1 combination screen pre-eclampsia small -for-gestational age ( SGA ) fetuses 12-14 week gestation</brief_summary>
	<brief_title>Early Placental Insufficiency Screening</brief_title>
	<detailed_description>Pre-eclampsia ( PE ) intrauterine growth restriction ( IUGR ) know major factor perinatal morbidity mortality . Routine antenatal care focus detection woman increase risk apply population program careful monitoring appropriate intervention . Uterine artery Doppler anomaly scan 12 14 week select woman increase risk , prove accurate detect develop PE IUGR second half pregnancy . A variety angiogenic protein study potential marker pre-eclampsia . Among protein Plgf sflt-1 respectively demonstrate high low level pregnant woman subsequently develop pre-eclampsia . Our study aim evaluate performance serum Plgf sflt-1 measurement association uterine artery Doppler screening placental insufficiency .</detailed_description>
	<mesh_term>Pre-Eclampsia</mesh_term>
	<mesh_term>Eclampsia</mesh_term>
	<mesh_term>Placental Insufficiency</mesh_term>
	<criteria>Chronic hypertension medication Insulin insulin dependant preexist diabetes Previous history preeclampsia Previous history unexplained stillbirth Previous history placental abruption Previous history SGA ( &lt; 10th centile ) History preeclampsia chronic hypertension 45 year mother sister History vascular pathology 50 year father Obesity ( BMI &gt; 26 ) Nulliparous 38 year Assisted conception donor Primipaternity 38 year old 20 year old Multiple pregnancy Pregnancy require termination Unability understand study Thrombophilia treatment heparin</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>Pre-eclampsia</keyword>
</DOC>